Evolus Logo Nov 2018.png
Evolus to Participate in Two Upcoming Investor Conferences
April 29, 2019 08:00 ET | Evolus
IRVINE, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced...
Evolus Logo Nov 2018.png
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
April 26, 2019 08:50 ET | Evolus
NEWPORT BEACH, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus to Release First Quarter 2019 Financial Results and Provide a Business Update on Tuesday, April 30, 2019
April 24, 2019 16:05 ET | Evolus
IRVINE, Calif., April 24, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced...
Evolus Logo Nov 2018.png
Evolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveau™ and BOTOX® in Aesthetic Surgery Journal
April 08, 2019 07:00 ET | Evolus
Primary Endpoint of Non-Inferiority Achieved with Responder Rates* of 87.2% for Jeuveau™, 82.8% for BOTOX® and 4.2% for Placebo at Day 30 Secondary and Exploratory Analyses Unveil Additional...
Evolus Logo Nov 2018.png
Evolus Provides Regulatory Update on Nuceiva™ in the European Union
April 01, 2019 09:00 ET | Evolus
NEWPORT BEACH, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus Announces Publication of U.S. Phase III Pivotal Trial Results for Jeuveau™ in Dermatologic Surgery
March 21, 2019 08:00 ET | Evolus
NEWPORT BEACH, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus Reports Fourth Quarter and Full Year 2018 Results
March 18, 2019 16:04 ET | Evolus
Received U.S. FDA Approval of Jeuveau™ on February 1, 2019 Majority of Sales Force Hired with Launch Planned in the Coming Weeks Hosting Investor & Analyst Day on May 8th, 2019 in New York, NY ...
Evolus Logo Nov 2018.png
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
March 18, 2019 16:01 ET | Evolus
NEWPORT BEACH, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus to Release Fourth Quarter and Full Year 2018 Financial Results and Provide a Business Update on Monday, March 18, 2019
March 15, 2019 16:01 ET | Evolus
IRVINE, Calif., March 15, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced...
Evolus Logo Nov 2018.png
Evolus Appoints Crystal Muilenburg as Vice President Corporate Communications & Public Relations
February 27, 2019 09:00 ET | Evolus
NEWPORT BEACH, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on delivering breakthrough products, today announced the appointment...